MedTrace Logo

Impact of Health Education on Knowledge, Attitude and Practice of Post-exposure Prophylaxis

NCT07330427 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 340

Last updated 2026-01-09

No results posted yet for this study

Summary

Occupational exposure to blood-borne pathogens, such as human immune-deficiency virus (HIV), hepatitis B virus (HBV), and hepatitis C virus (HCV) for healthcare workers through contact with human blood and body fluids has become a major health concern as it poses a risk of transmission of these infectious agents.

According to the World Health Organization (WHO) report, about three million HCWs are exposed to blood-borne pathogens each year, of which 170,000 are exposed to HIV infections, 2 million to HBV infections, and 0.9 million to HCV infections. Most of the time, healthcare providers get exposure through the splash of blood or other body fluids into the eyes, nose, or mouth or nonintact skin exposure, and percutaneous injury occurs as a result of a break in the skin caused by a needlestick or sharps contaminated with blood or body fluids

Conditions

  • Post Exposure Prophylaxis

Interventions

PROCEDURE

Health Education

1. Assess the baseline knowledge, attitudes and practices of health care workers at Aswan university hospital towards postexposure prophylaxis against blood-borne viral infection. 2. Provide an intense post exposure prophylaxis health education sessions. 3. Evaluate changes in post exposure prophylaxis knowledge, attitudes and practices after the health education intervention.

Sponsors & Collaborators

  • Aswan University

    lead OTHER

Principal Investigators

  • Shaimaa Sayed Abdelrheem, M.D · Associate Professor of Public Health and Community Medicine, Faculty of medicine, Aswan University

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
19 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-06-01
Primary Completion
2026-02-01
Completion
2026-02-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07330427 on ClinicalTrials.gov